Market Overview The US Asia Pacific lignocaine market is undergoing strategic restructuring as American healthcare stakeholders prioritize supply chain resilience following pandemic-era disruptions that exposed vulnerabilities in single-source dependencies and extended logistics networks. Pharmaceutical supply chain managers are diversifying Asia Pacific supplier portfolios, increasing safety...